365 related articles for article (PubMed ID: 21168330)
1. In vitro efficacy of 7-benzylamino-1-isoquinolinamines against Plasmodium falciparum related to the efficacy of chalcones.
Gutteridge CE; Hoffman MM; Bhattacharjee AK; Milhous WK; Gerena L
Bioorg Med Chem Lett; 2011 Jan; 21(2):786-9. PubMed ID: 21168330
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
3. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
Manohar S; Khan SI; Rawat DS
Chem Biol Drug Des; 2013 May; 81(5):625-30. PubMed ID: 23331618
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines.
De D; Krogstad FM; Byers LD; Krogstad DJ
J Med Chem; 1998 Dec; 41(25):4918-26. PubMed ID: 9836608
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds.
Guantai EM; Ncokazi K; Egan TJ; Gut J; Rosenthal PJ; Smith PJ; Chibale K
Bioorg Med Chem; 2010 Dec; 18(23):8243-56. PubMed ID: 21044845
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.
Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV
Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
[TBL] [Abstract][Full Text] [Related]
8. Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.
Sharma N; Mohanakrishnan D; Sharma UK; Kumar R; Richa ; Sinha AK; Sahal D
Eur J Med Chem; 2014 May; 79():350-68. PubMed ID: 24747290
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities.
Madrid PB; Sherrill J; Liou AP; Weisman JL; Derisi JL; Guy RK
Bioorg Med Chem Lett; 2005 Feb; 15(4):1015-8. PubMed ID: 15686903
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):481-4. PubMed ID: 19054674
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
[TBL] [Abstract][Full Text] [Related]
14. Plasmepsin II inhibitory activity of alkoxylated and hydroxylated chalcones.
Sriwilaijaroen N; Liu M; Go ML; Wilairat P
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):607-12. PubMed ID: 17121282
[TBL] [Abstract][Full Text] [Related]
15. Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
Blackie MA; Beagley P; Croft SL; Kendrick H; Moss JR; Chibale K
Bioorg Med Chem; 2007 Oct; 15(20):6510-6. PubMed ID: 17693090
[TBL] [Abstract][Full Text] [Related]
16. Piperazine-linked 4-aminoquinoline-chalcone/ferrocenyl-chalcone conjugates: Synthesis and antiplasmodial evaluation.
Singh A; Rani A; Gut J; Rosenthal PJ; Kumar V
Chem Biol Drug Des; 2017 Oct; 90(4):590-595. PubMed ID: 28332319
[TBL] [Abstract][Full Text] [Related]
17. A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity.
Hussain H; Specht S; Sarite SR; Saeftel M; Hoerauf A; Schulz B; Krohn K
J Med Chem; 2011 Jul; 54(13):4913-7. PubMed ID: 21591758
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones.
Geyer JA; Keenan SM; Woodard CL; Thompson PA; Gerena L; Nichols DA; Gutteridge CE; Waters NC
Bioorg Med Chem Lett; 2009 Apr; 19(7):1982-5. PubMed ID: 19250824
[TBL] [Abstract][Full Text] [Related]
19. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
20. Novel 4-aminoquinolines active against chloroquine-resistant and sensitive P. falciparum strains that also inhibit botulinum serotype A.
Solaja BA; Opsenica D; Smith KS; Milhous WK; Terzić N; Opsenica I; Burnett JC; Nuss J; Gussio R; Bavari S
J Med Chem; 2008 Aug; 51(15):4388-91. PubMed ID: 18637666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
